The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression

scientific article

The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1524-6175.2003.02464.X
P698PubMed publication ID12826766
P5875ResearchGate publication ID10690312

P2093author name stringWilliam C Cushman
P2860cites workEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsQ28144781
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesQ28188162
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesQ28188182
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>Q28204197
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research GroupQ28328155
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyQ29615215
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Q29618529
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupQ29619460
Localization and function of angiotensin AT1 receptorsQ33839720
Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertensionQ33898043
Clinical Advisory Statement. Importance of systolic blood pressure in older AmericansQ33922409
Hypertension and the prothrombotic stateQ34091945
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failureQ34106793
Salt sensitivity of blood pressure in humansQ34376900
Circadian rhythms and clinical medicine with applications to hypertensionQ34388682
Blood pressure, systolic and diastolic, and cardiovascular risks. US population dataQ36777424
Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureQ40797335
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart studyQ40804261
Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X")Q41101882
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertensionQ41457287
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertensionQ41943327
Heart rate and cardiovascular mortality: the Framingham StudyQ43463488
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.Q43576144
Relationships between 24 h blood pressure load and target organ damage in patients with mild-to-moderate essential hypertensionQ43717162
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.Q45952917
Cardiovascular abnormalities in never-treated hypertensives according to nondipper statusQ48783510
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Q50934595
NaCl sensitivity of essential hypertensive patients is related to insulin resistance.Q51571806
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.Q53328876
Association between salt sensitivity and target organ damage in essential hypertension.Q54040028
P433issue3 Suppl 2
P407language of work or nameEnglishQ1860
P921main subjecthypertensionQ95566669
P304page(s)14-22
P577publication date2003-05-01
P1433published inJournal of Clinical HypertensionQ15764150
P1476titleThe burden of uncontrolled hypertension: morbidity and mortality associated with disease progression
P478volume5

Reverse relations

cites work (P2860)
Q60800106A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkers
Q34568191Accelerated NaCl-induced hypertension in taurine-deficient rat: role of renal function
Q51638920Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens
Q44701637Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy
Q43144878Aspirin, non-aspirin analgesics and the risk of hypertension in the SUN cohort
Q59305271Aspirina, analgésicos y riesgo de hipertensión arterial en la Cohorte SUN
Q44064985Can the presence of carotid artery calcification on panoramic radiographs predict the risk of vascular diseases among 80-year-olds?
Q35685416Cardiovascular mortality among a cohort of hypertensive and normotensives in Rio de Janeiro - Brazil - 1991-2009
Q34623401Child maltreatment and blood pressure in young adulthood
Q38691197Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV.
Q36818650Effects of aerobic exercise and drug therapy on blood pressure and antihypertensive drugs: a randomized controlled trial
Q46713618Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study
Q90448934Factors associated with dietary adherence to the guidelines for prevention and treatment of hypertension among Korean adults with and without hypertension
Q35771491Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
Q36731015Incidence of autonomic dysreflexia and silent autonomic dysreflexia in men with spinal cord injury undergoing sperm retrieval: implications for clinical practice.
Q39531841Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE-Inhibitory Peptides
Q24672576Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study
Q37315597Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy.
Q57463907Medication non-adherence and blood pressure control among hypertensive migrant and non-migrant populations of sub-Saharan African origin: the RODAM study
Q36274546Receiving and adhering to lifestyle modification counseling for hypertension: disparities between smokers and nonsmokers
Q46440779Self-reported quality of life before and after aerobic exercise training in individuals with hypertension: a randomised-controlled trial
Q50917311Structure-based design and optimization of antihypertensive peptides to obtain high inhibitory potency against both renin and angiotensin I-converting enzyme.
Q36626136Translating basic behavioral and social science research to clinical application: the EVOLVE mixed methods approach
Q35210583Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility

Search more.